Annual accounts
Small accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
MAXION THERAPEUTICS LIMITED
Active- 12560803Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- C/O Mishcon De Reya, Africa House, 70 Kingsway, London WC2B 6AH
- Classification (SIC)
- Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)
- Accounts type
- Small
Company activity
Every document filed at Companies House for this company.
Pre-Score for UK companies is coming soon
- 18/05/2026View PDF (1 pages)
Termination of appointment of Emma Johnson as a director on 2025-12-11
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 10/05/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures MAXION THERAPEUTICS LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£5.06M2024
-48.17%vs 20232023: £9.77M
Total Assets
£5.81M2024
-42.94%vs 20232023: £10.18M
Cash in Bank
£3.46M2024
-57.52%vs 20232023: £8.14M
Total Liabilities
£743.63K2024
82.46%vs 20232023: £407.56K
Employees
302024
+11vs 20232023: 19
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Net assets moved furthest, down 48.17% on 2023. See the full financial analysis for MAXION THERAPEUTICS LIMITED.
The full financial record
Four ways through MAXION THERAPEUTICS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Cash in Bank · +264% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 30 | +11 |
| 2023 | 19 | +13 |
| 2022 | 6 | +2 |
| 2021 | 4 | – |
Reported employee count increased from 4 in 2021 to 30 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
14Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 16/04/2020–Present | 2 | |
| Director | 30/03/2022–31/01/2023 | 3 | |
| Director | 03/02/2023–Present | 7 | |
| Director | 03/02/2023–Present | 9 | |
| Director | 13/09/2023–Present | 5 | |
| Secretary | 15/04/2020–31/01/2023 | 0 | |
| Director | 31/03/2022–Present | 0 | |
| Director | 31/03/2022–21/02/2025 | 1 | |
| Director | 21/02/2025–11/12/2025 | 8 | |
| Director | 03/02/2023–Present | 2 | |
| Director | 01/03/2024–Present | 0 | |
| Director | 21/02/2025–Present | 0 | |
| Director | 17/07/2025–Present | 0 | |
| Director | 03/06/2026–Present | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 16/04/2020–07/03/2025 | 2 | |
| 16/04/2020–Present | 2 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 1 Since 18/05/2026
- Last 12 months
- 1
- Most recent filing
- 18/05/2026 4 months ago
What changed in the last year
- Officer changesLatest 18/05/2026
Filing timeline
- 18/05/2026View PDF (1 pages)
Termination of appointment of Emma Johnson as a director on 2025-12-11
See when the next accounts and confirmation statement are due
Similar companies
13 UK companies are similar to MAXION THERAPEUTICS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other research and experimental development on natural sciences and engineering) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
Active167-169 Great Portland Street, Fifth Floor, London W1W 5PF
- Activity
- Research and experimental development on biotechnology
- Company no.
- 04441512
- Incorporated
- 17/05/2002
- Employees
- 33
YOUSEQ LTD
Active8 Moorside Place, Moorside Road, Winchester, Hampshire SO23 7FX
- Activity
- Research and experimental development on biotechnology
- Company no.
- 11595406
- Incorporated
- 29/09/2018
- Employees
- 39
CCM TECHNOLOGIES LIMITED
ActiveKingston House Lydiard Fields, Great Western Way, Swindon SN5 8UB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 07633047
- Incorporated
- 13/05/2011
- Employees
- 30
EXCELLERATE BIOSCIENCE LIMITED
ActiveNg2 Business Park, 21 The Triangle, Nottingham NG2 1AE
- Activity
- Research and experimental development on biotechnology
- Company no.
- 10228159
- Incorporated
- 13/06/2016
- Employees
- 31
GYLDEN PHARMA LIMITED
Active4 & 5 Dunmore Court Wootton Road, Abingdon, Oxfordshire OX13 6BH
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09955881
- Incorporated
- 18/01/2016
- Employees
- 36
About MAXION THERAPEUTICS LIMITED
A short description of the company, written from its Companies House record.
MAXION THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, based in C/O Mishcon De Reya, Africa House, 70 Kingsway, London WC2B 6AH. Companies House classifies its business as Other research and experimental development on natural sciences and engineering. It has been on the register for 6 years 5 months.
The register currently records it as active. Its 2024 accounts report net assets of £5.06M and 30 employees.
MAXION THERAPEUTICS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does MAXION THERAPEUTICS LIMITED do?
Companies House records MAXION THERAPEUTICS LIMITED under one registered business activity: Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007).
Is MAXION THERAPEUTICS LIMITED still active?
MAXION THERAPEUTICS LIMITED is recorded as active on the Companies House register, and has been on it since 16/04/2020.
What are MAXION THERAPEUTICS LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2024 and report net assets of £5.06M, total assets of £5.81M, cash in bank of £3.46M and total liabilities of £743.63K.
When did MAXION THERAPEUTICS LIMITED last file with Companies House?
The most recent document on the record is dated 18/05/2026: Termination of appointment of Emma Johnson as a director on 2025-12-11, 4 months ago.
When are MAXION THERAPEUTICS LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs MAXION THERAPEUTICS LIMITED?
Companies House lists 14 officers (10 currently in post) and 2 people with significant control (1 current).